Clinical trials
Active, not recruiting Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 2 |
| Dana-Farber Cancer Institute | 1 |
| MacroGenics | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Orca Biosystems, Inc. | 1 |
| Shenzhen TargetRx Co., Ltd. | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 8 |
| Myelodysplastic Syndromes | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Non-Hodgkin | 3 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 2 |
| Lymphohistiocytosis, Hemophagocytic | 2 |
| Lymphoproliferative Disorders | 2 |
| Blast Crisis | 1 |
| Epstein-Barr Virus Infections | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.